DAPAGLIF10MG14TAB

Dapaglif is a prescription medication containing Dapagliflozin, which belongs to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. It is primarily used to improve glycemic control in adults with type 2 diabetes mellitus. By inhibiting the reabsorption of glucose in the kidneys, it promotes the excretion of excess sugar through urine. Additionally, it is indicated for the management of heart failure and chronic kidney disease in specific patient populations to reduce the risk of hospitalization and cardiovascular death.